Robert Ballotti

7PUBLICATIONS
37CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersMetabolic medicineBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Luca Di Leo, Chiara Pagliuca, Ali Kishk

|Nov 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau, Imène Krossa, Chrystel Husser

|Apr 03, 2021
Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells.

Nelly Durand, Méliné Simsir, Laurie Signetti

|Jan 19, 2021
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

Nadia Habel, Najla El-Hachem, Frédéric Soysouvanh

|Jan 12, 2021
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.

Emilie Jaune, Elisa Cavazza, Cyril Ronco

Pageof 2